Aneurysmal Subarachnoid Hemorrhage (SAH) - Market Insight, Epidemiology and Market Forecast - 2027

Aneurysmal Subarachnoid Hemorrhage (SAH) - Market Insight, Epidemiology and Market Forecast - 2027

  • Pages: 143
  • Geography: Global
  • Delivery Timeline: 24 Hours
  • Publication: Aug, 2018
  • SKU: DIMI0028
  • Single User License
    (20% Off)
    $6,250.00
  • Site License
    (30% Off)
    $12,500.00
  • Global License
    (40% Off)
    $18,750.00
Request Sample

Name*  
Email ID*  
Mobile*  
Company*  
Country*  
Zip Code*  
Address*  
Message*  
X

Request Sample Pages

Request Before Buy
Name*  
Email ID*  
Mobile*  
Company*  
Message*  
X

Inquire Before Buy

Send Friend
Name*  
Email ID*  
Mobile*  
Company*  
Message*  
X

Send to Friend

DelveInsight’s ‘Aneurysmal Subarachnoid Hemorrhage (aSAH)  - Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of aSAH in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. 
The Report provides the current treatment practices, emerging drugs having the potential to get launched in the forecast period, market share of the individual therapies, current and forecasted market size of aSAH from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.

Geography Covered

• The United States

• EU5 (Germany, France, Italy, Spain and the United Kingdom)

• Japan

Study Period: 2016-2027

Aneurysmal Subarachnoid Hemorrhage - Disease Understanding and Treatment Algorithm
The DelveInsight Aneurysmal Subarachnoid Hemorrhage market report gives the thorough understanding of aSAH by including details such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends. It also provides treatment algorithms and treatment guidelines for aSAH in the US, EU5, and Japan.

Aneurysmal Subarachnoid Hemorrhage Epidemiology
The aSAH epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken. 
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [Total incident population, Sex-specific incidence, Grade-wise incidence and Diagnosed  cases] scenario in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.
According to DelveInsight, total incident population of aSAH in 7 major markets were about 84,208 in 2016.

Aneurysmal Subarachnoid Hemorrhage Drug Chapters
This segment of the aSAH report encloses the detailed analysis of marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
There is no cure of the disease but to stabilize the patients and to further reduce the worsening of the condition, few medications and surgeries (aneurysmal clipping, endovascular exclusion) are performed based on the severity of the condition. The current aSAH therapeutic market is primarily dependent on Nimodipine which forms the current standard treatment of aSAH. The market is dominated by its generic versions as well but not without its fair share of disputes. Detailed chapter for upcoming therapies SFX-01 (Evgen Pharma) and Clazosentan (Actelion Pharamceuticals) have been covered in the report.

Aneurysmal Subarachnoid Hemorrhage Market Outlook
The aSAH market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. 
This segment gives a through detail of market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight. 
According to DelveInsight, the market of aSAH in 7MM was found to be USD 320.6 Billion in 2016.

Aneurysmal Subarachnoid Hemorrhage Drugs Uptake
This section focusses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2016-2027. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug.
This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Aneurysmal Subarachnoid Hemorrhage Report Insights

• Patient Population

• Therapeutic Approaches

• Pipeline Analysis

• Market Size and Trends

• Market Opportunities

• Impact of upcoming Therapies

Aneurysmal Subarachnoid Hemorrhage Report Key Strengths

• 10 Year Forecast

• 7MM Coverage

• Epidemiology Segmentation

• Drugs Uptake 

• Highly Analyzed Market

• Key Cross Competition

Aneurysmal Subarachnoid Hemorrhage Report Assessment

• Current Treatment Practices

• Unmet Needs

• Detailed Pipeline Product Profiles

• Market Attractiveness

• Market Drivers and Barriers

Key Benefits

• This DelveInsight report will help to develop Business Strategies by understanding the trends shaping and driving aSAH market.

• Organize sales and marketing efforts by identifying the best opportunities for aSAH market.

• To understand the future market competition in the aSAH market.

1. Key Insights 
2. Aneurysmal Subarachnoid Hemorrhage (aSAH) Market Overview at a Glance 
2.1. Market Share (%) Distribution of aSAH in 2017 
2.2. Market Share (%) Distribution of aSAH in 2027 
3. Disease Background and Overview: Aneurysmal Subarachnoid Hemorrhage 
3.1. Introduction 
3.2. Symptoms 
3.3. Etiology and Risk Factors 
3.4. Grading 
3.5. Pathophysiology 
3.6. Diagnosis 
3.7. Biomarkers 
3.8. Management 
4. Epidemiology and Patient Population 
4.1. Key Findings 
5. 7MM Total Incident Patient Population of Aneurysmal subarachnoid hemorrhage 
6. Country Wise-Epidemiology of Aneurysmal subarachnoid hemorrhage 
6.1. United States 
6.1.1. Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US 
6.1.2. Sex-Specific Incidence of Aneurysmal Subarachnoid Hemorrhage in the US 
6.1.3. Grade wise Incidence of Aneurysmal Subarachnoid Hemorrhage in the US 
6.1.4. Diagnosed cases of Aneurysmal Subarachnoid Hemorrhage in the US 
6.2. EU5 Countries 
6.2.1. Germany 
6.2.1.1. Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany 
6.2.1.2. Sex-Specific Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany 
6.2.1.3. Grade wise Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany 
6.2.1.4. Diagnosed cases of Aneurysmal Subarachnoid Hemorrhage in Germany 
6.2.2. France 
6.2.2.1. Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France 
6.2.2.2. Sex-Specific Incidence of Aneurysmal Subarachnoid Hemorrhage in France 
6.2.2.3. Grade wise Incidence of Aneurysmal Subarachnoid Hemorrhage in France 
6.2.2.4. Diagnosed cases of Aneurysmal Subarachnoid Hemorrhage in France 
6.2.3. Italy 
6.2.3.1. Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy 
6.2.3.2. Sex-Specific Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy 
6.2.3.3. Grade wise Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy 
6.2.3.4. Diagnosed cases of Aneurysmal Subarachnoid Hemorrhage in Italy 
6.2.4. Spain 
6.2.4.1. Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain 
6.2.4.2. Sex-Specific Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain 
6.2.4.3. Grade wise Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain 
6.2.4.4. Diagnosed cases of Aneurysmal Subarachnoid Hemorrhage in Spain 
6.2.5. United Kingdom 
6.2.5.1. Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the UK 
6.2.5.2. Sex-Specific Incidence of Aneurysmal Subarachnoid Hemorrhage in the UK 
6.2.5.3. Grade wise Incidence of Aneurysmal Subarachnoid Hemorrhage in the UK 
6.2.5.4. Diagnosed cases of Aneurysmal Subarachnoid Hemorrhage in the UK 
6.2.6. Japan 
6.2.6.1. Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan 
6.2.6.2. Sex-Specific Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan 
6.2.6.3. Grade wise Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan 
6.2.6.4. Diagnosed cases of Aneurysmal Subarachnoid Hemorrhage in Japan 
7. Treatment Algorithm, Current Treatment, and Medical Practices 
8. Unmet Needs 
9. Marketed drugs 
9.1. Nymalize: Arbor Pharmaceuticals 
9.1.1. Drug Description 
9.1.2. Mechanism of Action 
9.1.3. Regulatory Milestones 
9.1.4. Advantages & Disadvantages 
9.1.5. Safety and Efficacy 
9.1.6. Product Profile 
10. Emerging Drugs 
10.1. Key Cross Competition 
10.2. SFX-01: Evgen 
10.2.1. Product Description 
10.2.2. Regulatory Milestones 
10.2.3. Clinical Development 
10.2.4. Clinical Trials Information 
10.2.5. Safety and Efficacy 
10.2.6. Advantages and Disadvantages 
10.2.7. Product Profile 
10.3. Clazosentan: Actelion Pharmaceutical 
10.3.1. Product Description 
10.3.2. Regulatory Milestones 
10.3.3. Clinical Development 
10.3.4. Clinical Trials Information 
10.3.5. Safety and Efficacy 
10.3.6. Advantages and Disadvantages 
10.3.7. Product Profile 
11. Aneurysmal Subarachnoid Hemorrhage (aSAH): 7 Major Market Analysis 
Key Findings 
11.1. 7MM Market Size 
11.1.1. Total Market size of Aneurysmal subarachnoid hemorrhage (aSAH) 
11.2. The United States Market Outlook 
11.2.1. United States Market Size 
11.2.1.1. Total Market size of Aneurysmal subarachnoid hemorrhage (aSAH) 
11.2.1.2. Market Size by Therapies 
11.2.1.3. Emerging Therapies 
11.3. EU-5 Countries: Market Outlook 
11.3.1. Germany Market Size 
11.3.1.1. Total Market size of Aneurysmal subarachnoid hemorrhage (aSAH) 
11.3.1.2. Market Size by Therapies 
11.3.1.3. Emerging Therapies 
11.3.2. France Market Size 
11.3.2.1. Total Market size of Aneurysmal subarachnoid hemorrhage (aSAH) 
11.3.2.2. Market Size by Therapies 
11.3.2.3. Emerging Therapies 
11.3.3. Italy Market Size 
11.3.3.1. Total Market size of Aneurysmal subarachnoid hemorrhage (aSAH) 
11.3.3.2. Market Size by Therapies 
11.3.3.3. Emerging Therapies 
11.3.4. United Kingdom Market Size 
11.3.4.1. Total Market size of Aneurysmal subarachnoid hemorrhage (aSAH) 
11.3.4.2. Market Size by Therapies 
11.3.4.3. Emerging Therapies 
11.3.5. Spain Market Size 
11.3.5.1. Total Market size of Aneurysmal subarachnoid hemorrhage (aSAH) 
11.3.5.2. Market Size by Therapies 
11.3.5.3. Emerging Therapies 
11.4. Japan: Market Outlook 
11.4.1. Japan Market Size 
11.4.1.1. Total Market size of Aneurysmal subarachnoid hemorrhage (aSAH) 
11.4.1.2. Market Size by Therapies 
11.4.1.3. Emerging Therapies 
12. Market Drivers 
13. Market Barriers 
14. Appendix 
14.1. Report Methodology 
15. DelveInsight Capabilities 
16. Disclaimer 
17. About DelveInsight 

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 48: Diagnosed cases of aSAH in Japan (2016-2027)
Figure 49: Cerebral angiography of a ruptured aneurysm at the basilar tip before endovascular coiling (arrow) and immediately after endovascular coiling
Figure 50: Endovascular Coiling of Ruptured Intracranial Aneurysm: platinum coil after deployment
Figure 51: Unmet Needs of aSAH
Figure 52: Market Size of aSAH in 7MM, USD Million (2016-2027)
Figure 53: Market Size of aSAH in the United States, USD Million (2016-2027)
Figure 54: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Figure 55: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Figure 56: Market Size of aSAH in Germany, USD Million (2016-2027)
Figure 57: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Figure 58: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Figure 59: Market Size of aSAH in France, USD Million (2016-2027)
Figure 60: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Figure 61: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Figure 62: Market Size of aSAH in Italy, USD Million (2016-2027)
Figure 63: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Figure 64: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Figure 65: Market Size of aSAH in the UK, USD Million (2016-2027)
Figure 66: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Figure 67: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Figure 68: Market Size of aSAH in Spain, USD Million (2016-2027)
Figure 69: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Figure 70: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Figure 71: Market Size of aSAH in Japan, USD Million (2016-2027)
Figure 72: Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Figure 73: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)
Figure 74: Market Drivers
Figure 75: Market Barriers

 

Table 1: Total Incident Population of  Aneurysmal Subarachnoid in the 7MM (2016-2027)
Table 2: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 3: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 4: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 5: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 6: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Table 7: Diagnosed cases of aSAH in the US (2016-2027)
Table 8: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 9: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 10: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 11: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 12: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Table 13: Diagnosed cases of aSAH in Germany (2016-2027)
Table 14: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 15: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 16: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 17: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 18: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Table 19: Diagnosed cases of aSAH in France (2016-2027)
Table 20: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 21: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 22: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 23: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 24: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Table 25: Diagnosed cases of aSAH in Italy (2016-2027)
Table 26: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 27: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 28: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 29: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 30: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Table 31: Diagnosed cases of aSAH in Spain (2016-2027)
Table 32: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 33: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 34: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 35: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 36: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Table 37: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Table 38: Total Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 39: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 40: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 41: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 42: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Table 43: Diagnosed cases of aSAH in Japan (2016-2027)
Table 44: Comparison of emerging drugs under development
Table 45: SFX-01, Clinical Trial Description, 2017
Table 46: Clazosentan, Clinical Trial Description, 2018
Table 47: 7MM Market Size of aSAH in USD Million (2016-2027)
Table 48: United States Market Size of aSAH in USD Million (2016-2027)
Table 49: Market size of aSAH by therapies in the United States, in USD Million (2016-2027)
Table 50: Market size of aSAH by emerging therapies in the United States, in USD Million (2016-2027)
Table 51: Germany Market Size of aSAH in USD Million (2016-2027)
Table 52: Market size of aSAH by therapies in Germany, in USD Million (2016-2027)
Table 53: Market size of aSAH by emerging therapies in Germany, in USD Million (2016-2027)
Table 54: France Market Size of aSAH in USD Million (2016-2027)
Table 55: Market size of aSAH by therapies in France, in USD Million (2016-2027)
Table 56: Market size of aSAH by emerging therapies in France, in USD Million (2016-2027)
Table 57: Italy Market Size of aSAH in USD Million (2016-2027)
Table 58: Market size of aSAH by therapies in Italy, in USD Million (2016-2027)
Table 59: Market size of aSAH by emerging therapies in Italy, in USD Million (2016-2027)
Table 60: The UK Market Size of aSAH in USD Million (2016-2027)
Table 61: Market size of aSAH by therapies in the UK, in USD Million (2016-2027)
Table 62: Market size of aSAH by emerging therapies in the UK, in USD Million (2016-2027)
Table 63: Spain Market Size of aSAH in USD Million (2016-2027)
Table 64: Market size of aSAH by therapies in Spain, in USD Million (2016-2027)
Table 65: Market size of aSAH by emerging therapies in Spain, in USD Million (2016-2027)
Table 66: Japan Market Size of aSAH in USD Million (2016-2027)
Table 67:Market size of aSAH by therapies in Japan, in USD Million (2016-2027)
Table 68: Market size of aSAH by emerging therapies in Japan, in USD Million (2016-2027)

 

Figure 1: Layers of a Normal Arterial Wall
Figure 2: Common Aneurysm Locations within the Circle of Willis
Figure 3: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
Figure 4: CT Scan Showing Subarachnoid Blood
Figure 5: Angiographic Film Showing Cerebral Aneurysm Before Treatment
Figure 6: Total Incident Patient Population of Aneurysmal Subarachnoid in the 7MM (2016-2027)
Figure 7: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United States (2016-2027)
Figure 8: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 9: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 10: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 11: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the US (2016-2027)
Figure 12: Diagnosed cases of aSAH in the US (2016-2027)
Figure 13: Incidence of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 14: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 15: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany
Figure 16: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 17: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Germany (2016-2027)
Figure 18: Diagnosed cases of aSAH in Germany (2016-2027)
Figure 19: Incidence of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 20: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 21: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France
Figure 22: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 23: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in France (2016-2027)
Figure 24: Diagnosed cases of aSAH in France (2016-2027)
Figure 25: Incidence of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 26: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 27: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy
Figure 28: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 29: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Italy (2016-2027)
Figure 30: Diagnosed cases of aSAH in Italy (2016-2027)
Figure 31: Incidence of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 32: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 33: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain
Figure 34: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 35: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Spain (2016-2027)
Figure 36: Diagnosed cases of aSAH in Spain (2016-2027)
Figure 37: Incidence of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 38: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 39: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom
Figure 40: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 41: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in the United Kingdom (2016-2027)
Figure 42: Diagnosed cases of aSAH in the United Kingdom (2016-2027)
Figure 43: Incidence of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 44: Sex-Specific Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 45: WFNS Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan
Figure 46: Fisher Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage in Japan (2016-2027)
Figure 47: Hunt Hess Grade wise Incident Population of Aneurysmal Subarachnoid Hemorrhage